Purification and functional reconstitution of the human P2Y12 receptor

被引:62
作者
Bodor, ET [1 ]
Waldo, GL [1 ]
Hooks, SB [1 ]
Corbitt, J [1 ]
Boyer, JL [1 ]
Harden, TK [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1124/mol.64.5.1210
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human P2Y(12) receptor (P2Y(12)-R) is a member of the G protein coupled P2Y receptor family, which is intimately involved in platelet physiology. We describe here the purification and functional characterization of recombinant P2Y(12)-R after high-level expression from a baculovirus in Sf9 insect cells. Purified P2Y(12)-R, Gbeta(1)gamma(2), and various Galpha-subunits were reconstituted in lipid vesicles, and steady-state GTPase activity was quantified. GTP hydrolysis in proteoliposomes formed with purified P2Y(12)-R and Galpha(i2)beta(1)gamma(2) was stimulated by addition of either 2-methylthio-ADP (2MeSADP) or RGS4 and was markedly enhanced by their combined presence. 2MeSADP was the most potent agonist (EC50 = 80 nM) examined, whereas ADP, the cognate agonist of the P2Y(12)-R, was 3 orders of magnitude less potent. ATP had no effect alone but inhibited the action of 2MeSADP; therefore, ATP is a relatively low-affinity antagonist of the P2Y(12)-R. The G protein selectivity of the P2Y(12)-R was examined by reconstitution with various G protein alpha-subunits in heterotrimeric form with Gbeta(1)gamma(2). The most robust coupling of the P2Y(12)-R was to Galpha(i2), but effective coupling also occurred to Galpha(i1) and Galpha(i3). In contrast, little or no coupling occurred to Galpha(o) or Galpha(q). These results illustrate that the signaling properties of the P2Y(12)-R can be studied as a purified protein under conditions that circumvent the complications that occur in vivo because of nucleotide metabolism and interconversion as well as nucleotide release.
引用
收藏
页码:1210 / 1216
页数:7
相关论文
共 40 条
  • [1] Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
    Abbracchio, MP
    Boeynaems, JM
    Barnard, EA
    Boyer, JL
    Kennedy, C
    Miras-Portugal, MT
    King, BF
    Gachet, C
    Jacobson, KA
    Weisman, GA
    Burnstock, G
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) : 52 - 55
  • [2] Boyer JL, 1996, DRUG DEVELOP RES, V39, P253, DOI 10.1002/(sici)1098-2299(199611/12)39:3/4<253::aid-ddr4>3.0.co
  • [3] 2-q
  • [4] BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140
  • [5] BURNSTOCK G, 1972, PHARMACOL REV, V24, P509
  • [6] Identification of a novel human ADP receptor coupled to Gi
    Communi, D
    Gonzalez, NS
    Detheux, M
    Brézillon, S
    Lannoy, V
    Parmentier, M
    Boeynaems, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 41479 - 41485
  • [7] ADP IS A POTENT INHIBITOR OF HUMAN-PLATELET PLASMA-MEMBRANE ADENYLATE-CYCLASE
    COOPER, DMF
    RODBELL, M
    [J]. NATURE, 1979, 282 (5738) : 517 - 518
  • [8] The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets
    Dangelmaier, C
    Jin, JG
    Daniel, JL
    Smith, JB
    Kunapuli, SP
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08): : 2283 - 2289
  • [9] Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets
    Daniel, JL
    Dangelmaier, C
    Jin, JG
    Ashby, B
    Smith, JB
    Kunapuli, SP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) : 2024 - 2029
  • [10] Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
    Fabre, JE
    Nguyen, MT
    Latour, A
    Keifer, JA
    Audoly, LP
    Coffman, TM
    Koller, BH
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1199 - 1202